Immunodeficiency 87 and autoimmunityD81.4

Last updated on: 01.06.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Immunodeficiency-87 and autoimmunity, or IMD87, is an autosomal recessive immune disorder with variable phenotype and severity caused by a homozygous mutation in the DEF6 gene (610094) located on chromosome 6p21.

EtiopathogenesisThis section has been translated automatically.

The disease is primarily characterized by defects in T-cell function that cause both immune deficiency and overall immune dysregulation (Serwas et al. 2019 and Fournier et al. 2021).

ManifestationThis section has been translated automatically.

Infancy to early adolescence

Clinical featuresThis section has been translated automatically.

Affected individuals usually show increased susceptibility to infection, often with Epstein-Barr virus(EBV), in infancy or early childhood, as well as lymphadenopathy or autoimmune manifestations, especially hemolytic anemia.

LaboratoryThis section has been translated automatically.

Laboratory tests may show low or normal lymphocyte counts, often with a pathologic ratio of T-cell subsets.

Last updated on: 01.06.2022